Rattanaumpawan, P.; Jirajariyavej, S.; Lerdlamyong, K.; Palavutitotai, N.; Saiyarin, J.
Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. Antibiotics 2022, 11, 805.
https://doi.org/10.3390/antibiotics11060805
AMA Style
Rattanaumpawan P, Jirajariyavej S, Lerdlamyong K, Palavutitotai N, Saiyarin J.
Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. Antibiotics. 2022; 11(6):805.
https://doi.org/10.3390/antibiotics11060805
Chicago/Turabian Style
Rattanaumpawan, Pinyo, Supunnee Jirajariyavej, Kanokorn Lerdlamyong, Nattawan Palavutitotai, and Jatuporn Saiyarin.
2022. "Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand" Antibiotics 11, no. 6: 805.
https://doi.org/10.3390/antibiotics11060805
APA Style
Rattanaumpawan, P., Jirajariyavej, S., Lerdlamyong, K., Palavutitotai, N., & Saiyarin, J.
(2022). Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. Antibiotics, 11(6), 805.
https://doi.org/10.3390/antibiotics11060805
